g A 10-year hip fracture risk of ≥3% as the threshold for initiating treatment is indicative, based on pharmacoeconomic analyses. Individuals with a 10-year hip fracture risk of 3% have a 10-year major osteoporotic fracture risk of ~20% and a total fracture risk of ~40%.